having a reasonable ammount of 2p in France should sell itself.Then the question should be asked, if not then why proceed with more with more capital spending on exploration. Lets get sales going b4 more spending.
ACW This biotech stock raised $11M in a risk-off environment. Its Alzheimer's drug could change the game
OAR Chris Judd's Talk Ya Book: Orthocell building on 'enormous potential' with steady growth - and US push to come
History-making uranium sample grades and an imminent drill run. Infini Resources is poised to transform in 2025